Junaid Zaman, PhD
Clinical Cardiac Electrophysiology · Los Angeles, CANPI 1588198303
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Acutus Medical, Inc. at 24.7% of the total. Reporting peaked in 2022 at $24,404 and has fallen 79.3% since, to $5,055 in 2025.
Across 216 payments — averaging $245.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acutus Medical, Inc.$13K
- Boston Scientific$11K
- Medical Device Business Services, Inc.$8K
- Biosense Webster, Inc.$8K
- Volta Medical Inc$6K
- Abbott$5K
- plus $3K from 8 others
Across 3 payments — averaging $8183.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$25K
What the payments were for
- Consulting fees$29,60056%
- Speaking & faculty fees$5,50010%
- Travel & lodging$6,32812%
- Food & beverage$11,60322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acutus Medical, Inc. | 12 | $13,078 |
| Boston Scientific | 62 | $10,615 |
| Medical Device Business Services, Inc. | 4 | $8,167 |
| Biosense Webster, Inc. | 37 | $8,052 |
| Volta Medical Inc | 3 | $5,684 |
| Abbott | 56 | $4,716 |
| Medtronic | 34 | $2,225 |
| Irhythm Technologies, Inc. | 1 | $183 |
| Cardiva Medical, Inc. | 1 | $104 |
| Cvrx, Inc. | 1 | $73 |
| Baxter Healthcare | 2 | $46 |
| Novartis | 1 | $45 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Cook Medical LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$14,505
- VersaCross Access Solution$6,096
- VX1$5,684
- AVEIR$2,072
- Farapulse$1,898
- EMBLEM MRI S-ICD$608
- ASSURITY$451
- Quadra Assura CRT Defibrillator$309
- Micra$293
- QUADRA ASSURA$262
- GALLANT$190
- ZIO XT Patch$183
- ALLURE QUADRA$181
- LUX-Dx Insertable Cardiac Monitor$175
- PulseSelect$170
- WATCHMAN FLX$157
- EnSite Precision Cardiac Mapping System$143
- GENERAL - THERAPIES$129
- QDOT MICRO Catheter$107
- CARDIVA VASCADE MVP XL VVCS 10-12F$104
How this compares
$53,031 in reported general payments places this provider in the 70th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $86,973 |
| XareltoRivaroxaban | 24 | $29,916 |
| EntrestoSacubitril/Valsartan | 15 | $12,390 |
| Metoprolol Succinate | 57 | $980 |
| Flecainide Acetate | 25 | $625 |
| Atenolol | 13 | $195 |
| Furosemide | 11 | $80 |
| Spironolactone | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $45 | $12,39015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Los Angeles
- Leslie SaxonLos Angeles$1.1M
- Rahul DoshiLos Angeles$469K
- Koonlawee NademaneeLos Angeles$446K
- Ivan HoLos Angeles$294K
- Eric BuchLos Angeles$213K
- Carlos MaciasLos Angeles$160K
- Olujimi AjijolaLos Angeles$159K
- Justin HayaseLos Angeles$100K
- Omar YasinLos Angeles$87K
- Shephal DoshiSanta Monica$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.